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Abstract The central role of the adipose tissue in lipid
metabolism places speciﬁc demands on the cell structure of
adipocytes. The protein composition and dynamics of the
extracellular matrix (ECM) is of crucial importance for the
functioning of those cells. Adipogenesis is a bi-phasic
process in which the ECM develops from a ﬁbrillar to a
laminar structure as cells move from the commitment
phase to the growth phase characterized by storage of vast
amounts of triglycerides. Mature adipocytes appear to
spend a lot of energy on the maintenance of the ECM.
ECM remodeling is mediated by a balanced complement of
constructive and destructive enzymes together with their
enhancers and inhibitors. ECM remodeling is an energy
costing process regulated by insulin, by the energy
metabolism, and by mechanical forces. In the obese,
overgrowth of adipocytes may lead to instability of the
ECM, possibly mediated by hypoxia.
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Introduction
The global rise of overweight and obesity with the risk for
complications like type II diabetes and cardiovascular
disorders has intensiﬁed the attention on the metabolic and
physiologic role of the adipose tissue. The major functions
of adipose tissue are:
• site for energy storage
• endocrine/paracrine regulator of energy metabolism
• thermal insulation of the body
• shock cushion to protect organs from mechanical
damage
Those functions place speciﬁc demands on the adipose
tissue with respect to its structure and composition. Here,
we review various aspects of the adipocyte extracellular
matrix (ECM) including its components, development,
regulation, and relation to obesity.
Adipose tissue is histologically categorized as a type of
loose connective tissue and, as such, collagen contributes
considerably to the non-cell mass of this tissue. At least
partly, this collagen is produced by the adipocytes, but cells
of the stromal vascular fraction containing preadipocytes,
capillary endothelial cells, inﬁltrated monocytes/macro-
phages, and a population of multipotent stem cells can also
contribute to it. It was reported that each adipocyte is
surrounded by a thick ECM referred to as basal lamina
containing collagen IV as a major component [1]. This
characteristic is shared with cells of bone and cartilage,
which is not surprising since adipocytes, osteoblasts, and
chondrocytes are all of mesenchymal origin. However,
while a strong ECM is the principal functional entity of
bone and cartilage, the basal lamina of adipose tissue may
be more of a necessity for survival of the adipocytes.
Mature human adipocytes store triglycerides in a single fat
droplet that almost entirely ﬁlls the cell volume. Since only
a lipid monolayer forms the boundary between stored fat
and cytosol, mechanical stress on such an organelle may
easily lead to disruption. Transfer of mechanical stress
from the outside to the inside of the cell can be decreased
E. C. M. Mariman (&)  P. Wang
Department of Human Biology, NUTRIM School for Nutrition,
Toxicology and Metabolism, Maastricht University,
P.O. Box 616, 6200 MD Maastricht, The Netherlands
e-mail: e.mariman@hb.unimaas.nl
Cell. Mol. Life Sci. (2010) 67:1277–1292
DOI 10.1007/s00018-010-0263-4 Cellular and Molecular Life Sciencesby the strong external skeleton. In addition, a strong
extracellular scaffold can by linking the basal lamina of
adipocytes diminish locally experienced mechanical stress
by spreading forces over a larger area of the tissue. A
speciﬁc requirement of the ECM for cell survival indicates
that the development of preadipocytes into fat-storing
adipocytes should be accompanied by speciﬁc changes in
the make-up of the ECM.
Adipocyte ECM protein composition
Since the function of the ECM will depend on, and thus
will be reﬂected by, its molecular make-up, it is important
to know which proteins have been identiﬁed so far as part
of the adipocyte ECM. Overall, the ECM of adipocytes
seems composed of the same proteins as found in other cell
types. It is more the relative quantity in which those
factors are combined that determines the cell-speciﬁcity of
the ECM. Furthermore, this composition is related to the
developmental stage, viability, and subtype of the
adipocytes. The two main classes of ECM proteins are
proteoglycans (Fig. 1) and ﬁbrous proteins to which most
published information is referring.
Early studies on the protein composition of the ECM
have used immunological techniques with or without pro-
tein labeling. In this way, Aratani and Kitagawa [2]
demonstrated the presence of collagen IV, laminin
complexes, and nidogen (entactin) in the ECM of mouse
3T3-L1 adipocytes. In differentiated bovine intramuscular
preadipocytes (BIP), Nakajima et al. [3] showed the pres-
ence of type I–VI collagens, laminin and ﬁbronectin,
whereas based on staining, type II collagen was found to
have an extremely low abundance. With the emerging of
proteomics techniques, several studies of the adipocytes
secretome have been performed. From those, an impression
can be obtained on the protein composition of the adipo-
cyte ECM. Based on current literature [2–13], a list of core
proteins annotated to be part of the adipocyte ECM is
shown in Table 1. This leaves out those proteins that are
presently described as secreted or membrane proteins,
some of which might interact with the ECM. Although
there are a number of microarray studies on adipocytes, we
have exclusively focused on proteomics data to avoid
possible discrepancies between mRNA and protein levels.
Altogether, 20 subunits of 12 different types of collagen
have been identiﬁed from rodent cells, whereas subunits of
collagens II, XI, and XXIII were not found with human
visceral adipocytes. This might suggest species- or fat
depot-speciﬁc differences. However, the failure to detect a
protein cannot be taken as proof of its absence, because the
chance of detection depends on the biochemical charac-
teristics of a protein, on experimental conditions, and on
employed proteomics techniques [14].
Compared to other ECM components, collagen VI
seems more speciﬁc for adipocytes. It is highly enriched in
adipocytes, and there is evidence of its contribution to the
pathology of obesity-related diseases [15, 16]. The pres-
ence of all three subunits, a1(VI), a2(VI), and a3(VI), is
required for the stable formation of collagen VI [17]. Using
the yeast two-hybrid system, collagen VI was shown to be
able to strongly bind to collagen IV, an important com-
ponent of the basement membrane. Both collagens are
classiﬁed as non-ﬁbrillar types and their interaction has
been suggested to mediate anchoring of the basement
membrane to cells. Collagen VI has also been shown to
Fig. 1 Visualization of the
ECM of 3T3-L1 preadipocyte
(a) and adipocytes (b)b y
immunohistological staining of
heparin sulfate proteoglycan:
green heparin sulfate
proteoglycans stained by
antibody (10E4 epitope;
Seikagaku, Tokyo, Japan);
red nuclear stained with
propidium iodide. The fat
droplets are visible as dark
vesicles in the cytosol
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1280 E. C. M. Mariman, P. Wanginteract with other matrix proteins like proteoglycans and
ﬁbronectin. One study reported on the composition of
adiposomes from mouse 3T3-L1 cells, the vesicles by
which adipocytes are supposed to perform part of their
endocrine function with the secretion of adipokines [8].
ECM proteins may become part of those vesicles as con-
taminants during their transportation or experimental
preparation. On the other hand, the presence of collagens
may be natural, because procollagens are packed into
vesicles and secreted as such into the extracellular space.
Remarkably, only collagen types I and VI were detected in
adiposomes. It suggests that these collagens are speciﬁcally
involved in the secretion of adipokines through those
vesicles.
Biphasic ECM development during adipogenesis
The developmental dynamics of the ECM proteins has
mainly been studied in vitro using differentiation of mouse
3T3-L1 preadipocytes. Aratani and Kitagawa [2] found a
strong up-regulation of collagen IV, nidogen-1 (entactin),
and various laminin complexes during the ﬁrst few days of
a 6-day differentiation period indicating the transition from
a ﬁbrillar to a laminar make-up.
Studies on the adipocyte secretome during adipogenesis
also reveal useful information on the ECM components.
Notably, in vitro cell culture medium contains not only
intact or detached ECM components but also processing
byproducts and degradation products of the ECM. There-
fore, the amount of ECM proteins in the secretome may
reﬂect both synthesis and degradation. Our group observed
different patterns of expression for the various collagens
detected in the medium during a 12-day period of differ-
entiation and growth of 3T3-L1 cells. In the early phase of
differentiation, there occurred a decrease of collagens type
I and type III, whereas at a later stage, their level returned
to that of day 0. The same pattern was found for the
C-terminal processing peptides of those collagens, sug-
gesting that the observed changes related to the synthesis of
collagen. In parallel with this decrease of ﬁbrillar colla-
gens, an increased liability of the cells to detach from the
culture dish was observed around day 4. An opposite pat-
tern was seen for the components of collagen VI. They
initially increased and later declined, but remained at a
higher level compared to day 0. Collagen IV, the major
collagen of the basal lamina, and collagen V gradually
increased during differentiation.
In the study of Molina et al. [9] with a 7-day differen-
tiation period of 3T3-L1 cells, the vast majority of secreted
proteins were seen to be down-regulated at day 1. How-
ever, most of the matrix components were around basal
level at day 1 and peaked at day 3, including laminins,
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Adipocyte extracellular matrix 1281nidogens, biglycan, lumican, SPARC, and EMILIN1. In
accordance with our observation, the same peaking
behavior was observed for the components of collagen VI.
Contrastingly, in this study, collagen IV subunit COL4A2
showed a similar peaking pattern as the other collagens
ending at 50% of their basal level on day 7.
The variation in the results of the above studies may be
ascribed to differences in protein preparation methods and
in the ways that the data are quantiﬁed. In keeping with the
biphasic pattern of collagen synthesis during differentiation
of mouse preadipocytes, Nakajima et al. [18] reported the
remodeling of collagen V and VI matrices using immu-
nohistochemical staining of BIP cells with distinct ECM
networks at days 4 and 10 of differentiation. What can be
concluded is that, in the ﬁrst days after the induction of
adipogenesis, ECM dynamics reaches one of its highest
levels with increasing production of components of the
basal lamina. In line with the biphasic production of ECM
components, the two phases of adipogenesis seem to be an
early phase of commitment and differentiation, and a
subsequent phase of cell growth characterized by massive
fat storage.
When in 1974 Green and Meuth [19] reported the
selection of the 3T3-L1 cell-line from Swiss mouse
embryos, they measured proline hydroxylation and from
that calculated the extent of collagen synthesis. The high
level of collagen synthesis conﬁrmed the ﬁbroblast origin
of those cells. During this assay, an interesting comparison
was made between 3T3-L1 and another clone, 3T3-M2.
The latter did not store fat and at the same time had a 50%
lower rate of proline hydroxylation. This raises the ques-
tion, whether collagen synthesis is a prerequisite for
differentiation and fat storage. Experimental evidence
exists in support of such a control mechanism.
Using ethyl-3,4-dihydroxybenzoate (EDHB) as a spe-
ciﬁc inhibitor of collagen synthesis, it has been shown that,
in TA1 cells, preadipocytes derived from mouse 10T1/2
embryonic cells, differentiation and triglyceride accumu-
lation were blocked in a dose-dependent manner [20]. This
effect was only obtained when EDHB was added to pre-
adipocytes but not when added to already differentiating
cells. This suggests that collagen synthesis may serve dif-
ferent purposes during the early and late stages of
adipocytes development. Early collagen synthesis seems a
permissive requirement for the onset of differentiation,
whereas late collagen synthesis may be more related to
speciﬁc functions of the adipocytes and the adipose tissue,
such as providing stability to the fat-storing cells. Such a
requirement of collagen synthesis for cell differentiation
may well be a general phenomenon and is not conﬁned to
preadipocytes [21].
AlsoinBIPcells,bothcollagensynthesisandtriglyceride
accumulationcouldbeinhibitedinadose-dependentmanner
by EDHB [22]. However, a stage-dependency was not
observed. Looking in detail at collagens I–VI, the synthesis
of all collagens except type III collagen was signiﬁcantly
affected with the most dramatic effects on collagens IV–VI.
Interestingly, based on measurements of triglyceride accu-
mulation, the inhibitory effect of EDHB on BIP cells could
bereversedtoasigniﬁcantextentbyculturingEDHB-treated
cells in wells coated with collagen V or VI. This indicates
that particularly the synthesis of collagens V and VI is
important for the collagen-dependent initiation of prea-
dipocyte differentiation and triglyceride storage.
Adipocyte ECM maintenance
The importance of the ECM for the function and survival
of the adipocytes was demonstrated when we investigated
protein-dynamics in mature non-dividing 3T3-L1 adipo-
cytes by stable isotope protein labeling [23]. Among the
limited number of examined proteins in this study there
were three ECM components, COL1A1, COL1A2, and
calreticulin. Both collagens showed the highest rate of
labelling among all investigated proteins. Moreover, the
calculated isomer-exchange rate for COL1A1 and
COL1A2 was 2:1, exactly the ratio by which they consti-
tute the triplex collagen type I ﬁbers indicating that the
synthesis of the collagen I subunits is coordinated. Lower,
but still considerable, labeling was seen for calreticulin and
for the ECM processing enzyme protein disulﬁde isomer-
ase (PDIA1 and PDIA3). What can be learned from this is
that there is a constant turnover of the adipocyte ECM even
in mature cells. Apparently adipocytes spend a lot of
attention and, likely, a lot of metabolic energy on the
maintenance of their ECM. It should be kept in mind,
however, that the high collagen synthesis may be an effect
of two-dimensional cell culture and may not accurately
reﬂect the in vivo situation.
ECM-dynamics: a role for ECM-protein processing
enzymes
The relatively high degree of collagen replacement in
mature adipocytes suggests that the ECM is under constant
turnover, which is mediated by enzymes promoting con-
struction of the ECM and enzymes involved in its
degradation. Accordingly, for mature adipocytes, there has
to be a balance between those processes, whereas during
preadipocyte differentiation this balance is shifted towards
the constructive factors. In Table 2, processing enzymes
are listed that have been detected at the protein level. The
constructive enzymes fall into two classes, the intracellular
enzymes involved in processing of precursors of ECM-
1282 E. C. M. Mariman, P. Wangproteins and the extracellular inhibitors of the degrading
enzymes. The degrading enzymes by themselves belong to
either of two systems [24], the ﬁbrinolytic system and the
matrix metalloproteinases (MMPs). Although adipocytes
express these enzymes, the contribution from the stromal
vascular fraction can be signiﬁcant [25].
The intracellular maturation of newly synthesized
ECM-proteins takes place in the ER. There, the proteins
undergo biochemical modiﬁcation of amino acid side-
chains. The ECM proteins then undergo processing by
proteolytic cleavage before they are assembled into the
ECM network. For collagen subunits, this can involve
proline- and lysine-hydroxylation and glycosylation and
removal of the N- and C-terminal peptides by procolla-
gen-N- and -C-collagenase, respectively. After processing,
proteins are self-assembled into monomers depending on
the type of collagens and are then secreted. Experiments
have shown how crucial can be the role of intracellular
processing enzymes. Ibrahim et al. [20] demonstrated the
inhibitory effect of EDHB on collagen protein synthesis,
but at the same time reported that early administration of
EDHB did not inﬂuence the mRNA level of collagen
6A2. Further, Nakajima et al. [22] showed that EDHB
inhibits the assembly of subunits into collagen molecules,
Table 2 ECM-protein processing enzymes
Gene name Symbol UniProtKB
accession
Location Reference
A desintegrin and metalloproteinase with
thrombospondin type 1motif, 1
ADAMTS1 Q9UHI8 Sec, ECM [11]
A desintegrin and metalloproteinase with thrombospondin motifs 4 ADAMTS4 O75173 Sec, ECM [4]
A desintegrin and metalloproteinase with thrombospondin motifs 5 ADAMTS5 Q9UNA0 Sec, ECM [11]
Colligin (collagen-binding protein) SERPINH1 P50454 ER [5]
Contrapsin-like protease inhibitor 6 serpina3n P09006 Sec [7]
Matrix metalloproteinase-1 MMP1 P03956 Sec, ECM [4, 13]
Matrix metalloproteinase-2 MMP2 P08253 Sec, ECM [4–9, 13]
Matrix metalloproteinase-9 MMP9 P14780 Sec, ECM [4, 7, 8]
Matrix metalloproteinase-10 MMP10 P09238 Sec, ECM [13]
Matrix metalloproteinase 14; membrane-type-1 matrix
metalloproteinase
MMP14; MT1-MMP P50281 ECM, cell membrane [37, 38]
Matrix metalloproteinase-19 MMP19 Q99542 Sec, ECM [11]
Metalloproteinase inhibitor 1 TIMP1 P01033 Sec, ECM [4, 7, 13]
Metalloproteinase inhibitor 2 TIMP2 P16035 Sec [6, 11, 13]
Peptidyl-prolyl cis–trans isomerase A (cyclophilin A) PPIA P62937 Cyt [6, 9]
Peptidyl-prolyl cis–trans isomerase B (cyclophilin B) PPIB P23284 ER [4, 9, 11, 13]
Peptidyl-prolyl cis–trans isomerase (FK506-binding protein 9) FKBP9 O95302 ER [9, 12]
Plasminogen activator inhibitor 1 SERPINE1 P05121 Sec [4, 7, 10, 13]
Procollagen C-proteinase (bone morphogenic protein 1) BMP1 P13497 Sec [11]
Procollagen C-proteinase enhancer protein PCOLCE Q15113 Sec [4, 6, 11, 13]
Procollagen-lysine,2-oxoglutarate 5-dioxygenase 1 PLOD1 Q02809 ER, cell membrane [9, 11]
Procollagen-lysine,2-oxoglutarate 5-dioxygenase 2 PLOD2 O00469 ER, cell membrane [11]
Procollagen-lysine,2-oxoglutarate 5-dioxygenase 3 PLOD3 O60568 ER, cell membrane [4, 11]
Prolyl 4-hydroxylase, alpha subunit P4HA1 P13674 ER [10, 12]
Protein-disulﬁde isomerase P4HB P07237 ER, cell membrane [4, 10]
Protein-disulﬁde isomerase A3 PDIA3 P30101 ER [4, 10, 13]
Protein-disulﬁde isomerase A4 PDIA4 P13667 ER [9]
Protein-disulﬁde isomerase A6 PDIA6 Q15084 ER [4, 9, 13]
Protein-lysine 6-oxidase LOX P28300 Sec [6, 11]
Lysyl-oxidase homologue 1 LOXL1 Q08397 Sec [11]
Transforming growth factor beta induced protein ig-h3 TGFBI Q15582 Sec, ECM [11]
Visceral adipose tissue-derived serine protease inhibitor (vaspin) SERPINA12 Q8IW75 Sec [35]
Sec Secreted, ECM extracellular matrix, ER endoplasmic reticulum, Cyt cytosol
Adipocyte extracellular matrix 1283which is in keeping with EDHB inﬂuencing a post-tran-
scriptional process of collagen formation. EDHB is
a structural analog of ascorbate and a-ketoglutarate
(2-oxoglutarate), which are both essential cofactors of the
enzyme prolyl hydroxylase (P4HA1). Apparently, this
enzyme activity is crucial for collagen formation and
preadipocytes differentiation. Notably, EDHB is not spe-
ciﬁc for this particular enzyme but is an inhibitor for the
whole family of prolyl hydroxylases [26].
Extracellular procollagen processing involves the
cleaving-off of both N-terminal and C-terminal peptides
[27]. Procollagen I/II amino propeptide-processing enzyme
(ADAMTS-2) cleaves the N-terminal propeptide from the
subunits of collagens I and II: COL1A1, COL1A2, and
COL2A1. Cleavage takes place after assembly of two 1A1-
and one 1A2-chains into a collagen type I monomer before
those monomers multimerize into ﬁbrils. The process
requires the native conformation of the procollagens in
which the N-terminus can adopt a hairpin structure. During
the reaction, an intermediate is formed that has lost the
N-propeptide from one 1A1-chain and from the 1A2-chain,
but still contains the propeptide on the other 1A1-chain.
Conformational changes in the N-terminus are suspected to
be involved in determining this deﬁned sequential cleavage
of the propeptides [28]. Mutations in ADAMTS-2 can give
rise to Ehlers–Danlos syndrome type VIIC in humans, a
defect of the cartilage. Procollagen amino propeptide-pro-
cessing activity has also been observed for gene family
members of ADAMTS-2. ADAMTS-3 can process pro-
collagen II but not procollagen I. Both N-proteinases lack
the activity to process collagen III. Collagen I processing
activity has also been observed for ADAMTS-14.
Collagen ﬁbril formation also requires that the C-ter-
minal peptides are removed from the subunits by
proteolytic cleavage [27]. For collagens I–III this is done
by the enzyme procollagen-C-proteinase, also referred to as
mammalian tolloid protein or bone morphogenic protein 1
(BMP1). In contrast to ADAMTS-2, native collagen
conformation is not a prerequisite for processing of the
C-terminus. In addition to collagens, this enzyme processes
the precursors of laminin 5 and biglycan, and of the
modifying enzyme lysyl oxidase (LOX). Via alternative
splicing, different isoforms of the C-proteinase can be
formed [27].
Plasmin is the active component of the ﬁbrinolytic
system. It is able to cleave not only ﬁbrin and von Willi-
brand factor but also some adipocyte ECM components:
ﬁbronectin, thrombospondin, and laminin. The activity of
plasmin is regulated by several other proteins including the
urokinase-type (u-PA) and the tissue-type (t-PA) plasmin-
ogen activators and plasminogen activator inhibitors (PAIs)
(Fig. 2). The effect of the ﬁbrinolytic system on adipose
tissue has been studied in the mouse by abolishing or over-
expressing one of those genes, but it is difﬁcult to ﬁt all
observations into a uniform effect-model ([24] and refer-
ences therein). The various ﬁndings suggest that this
system affects angiogenesis rather than directly inﬂuencing
ECM remodeling and adipogenesis. Sufﬁcient blood ﬂow
by angiogenesis favors adipose tissue formation. Never-
theless, PAI-1 seems able to prevent the degradation of the
ECM. Pharmacological inhibition of PAI-1 in different
studies with mice on a high fat diet leads to reduced body
weight, weight of fat depots, and adipocyte volume [29,
30]. Here, a higher blood vessel density in adipose tissue
was observed, but this may be the consequence of the
reduced volume of the fat pads.
More than 20 different members of the MMP family
have been identiﬁed. Although MMPs collectively degrade
ECM proteins, according to the UniProt database there is
some form of substrate speciﬁcity (Table 3). Changing
MMP expression in the mouse can inﬂuence adiposity.
Inactivation of MMP3 on a high-fat diet results in
increased development of adipose tissue with a hyper-
plastic as well as a hypertrophic response [31]. Similar
observations were made after inactivation of MMP9 and
MMP11 [24, 32]. Contrasting observations have been made
with pharmacological inhibition of MMPs in mice on a
high-fat diet. Co-inhibition of MMPs 2, 9, and 14 did not
inﬂuence adipose tissue development [33], whereas the
general inhibition of MMP activity led to a reduction in
adipose tissue weight [34]. These sometimes controversial
results reﬂect the complexity of MMP activity that depends
on relative concentrations of different MMPs, their sub-
strate speciﬁcity, and the activity of their inhibitors, the
tissue inhibitors of metalloproteinases (TIMPs), and per-
haps several others [24, 35].
No information can be obtained from the Uniprot
database about an MMP that has collagen VI as a substrate,
but recent investigations have provided information on this.
Fig. 2 Overview of some of the proteins involved in regulating the
maintenance and turnover of the adipocyte ECM
1284 E. C. M. Mariman, P. WangStudies on breast cancer have indicated that adipocytes
may support cancer cells. In this context, a role for collagen
VI has been put forward [15]. Also, it was observed that
MMP11 is associated with tumor invasion and poor prog-
nosis. Further studies showed that COL6A3 is a substrate
of MMP11 [36]. Moreover, MMP11 appears to be a strong
negative regulator of adipogenesis [37] in line with the
above-mentioned observations in MMP11 deﬁcient mice.
All MMPs are secreted as inactive zymogens and need
proteolytic cleavage to become activated by other MMPs
or plasmin. The MMP most often reported in proteomics
studies is MMP2 cleaving the basal lamina component
collagen IV (Table 3). MMP2, as well as MMP13 (colla-
genase 3), is activated by MMP14 (MT1-MMP). Chun
et al. [38] observed that adipocytes from MT1-MMP
null-mice were 109— smaller in diameter than wild-type
adipocytes. Knock-out preadipocytes were able to differ-
entiate on planar interfaces but, when cultured in a 3D
matrix of collagen I ﬁbrils, they failed to differentiate and
did not accumulate triglycerides. The conclusion was that
MT1-MMP is necessary for the modulation of rigid peri-
cellular collagen to allow preadipocytes to grow out of the
stroma. Observations on vascular smooth muscle cells
indicate that MT1-MMP activity is also able to directly
remodel the matrix by itself [39].
Four TIMPs (Table 4) have been detected up to now
[40]. Like their counter players, the MMPs, TIMPs are
regulated during adipogenesis [41]. In relation to adipose
tissue development, TIMP1 has been studied the most
[42]. A recent report suggests that, beyond direct adipose
tissue ECM remodeling, TIMP1 may have an effect on
adipose tissue development by acting in the hypothala-
mus to regulate food intake [43]. Interestingly, TIMP4 is
speciﬁcally expressed in adipose tissue and adipocytes in
humans according to tissue-wide gene expression analy-
sis of UniGene [44] and GNF Gene Atlas [45], and is
highly regulated [46]. However, little is known about its
function for ECM remodeling and adipose tissue devel-
opment. Overall, it seems that the balance between
TIMPs and MMPs, or their ratio, is more relevant than
the activity of the individual groups of those processing
enzymes.
A subfamily of metalloproteinases is the A Desintegrin
And Metalloproteinase with Trombospondin motif (AD-
AMTS family). Members of this family have been found to
have procollagen N-proteinase activity as mentioned
above, but other members also may inﬂuence adipose tis-
sue development. In the mouse, expression of ADAMTS-1,
-4, -5, and -8 has been demonstrated in adipose tissue, and
their expression level changes during the development of
diet induced obesity. Expression seems highest in the
stromal vascular fraction, which is in line with a suggested
role in early steps of preadipocyte differentiation by the
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Adipocyte extracellular matrix 1285degradation of aggrecan, a chondroitin sulphate/keratan
sulphate proteoglycan [47].
Regulation of ECM dynamics
ECM regulation and insulin
Some years ago, we studied the inﬂuence of insulin on the
secretome of mature 3T3-L1 adipocytes [48]. Insulin
induced a clear increase of the mature form of COL1A1, of
a COL5A1 fragment, and of the C-terminal peptides of
COL1A1, COL1A2, and COL3A1. A comparison with
transcriptomics data showed that insulin did not up-regu-
late transcription of those genes. It was concluded that
insulin acts at the level of post-transcriptional processing
and secretion. In keeping with this, was the observed
increase in relative abundance of PCOLCE, procollagen
C-endopeptidase enhancer protein, that can activate the
C-endopeptidase by 20-fold. Remarkably, we observed a
signiﬁcant up-regulation of the mRNA levels for various
matrix protein processing enzymes including sulfatase 2
and prolyl hydroxylase, and a trend for increase of the
mRNA for PCOLCE. Altogether, our data indicate that
insulin up-regulates the transcription of genes for protein-
modifying and -processing enzymes and in that way
stimulates the formation of ECM-components and the
ECM as a whole. This activity seems not conﬁned to the
ECM components, as a considerable increase of other
secreted proteins was also observed without concomitant
increase of their mRNA levels including adipsin and
complement C3 [48]. In general, the observed effects of
adding insulin to the cell culture medium were even
stronger when the experiments were done in the presence
of extra glucose. The experiments leading to the above
effect of insulin activity mimic an acute increase in insulin
on mature adipocytes. For preadipocytes in vitro, insulin is
a potent stimulator of differentiation and triglyceride
storage in line with its general anabolic role.
The detection of up-regulated expression of the gene for
sulfatase 2 indicates that insulin changes the level of 6-O-
sulfation of heparan sulfate proteoglycans (HSPGs) [48].
Wilsie et al. [49] detected a clear inﬂuence of HSPGs on
lipid uptake in 3T3-L1 adipocytes. They propose a model
in which HSPG serves as a binding site for lipid particles
(apoE-VLDL). As such, a reaction center is created for the
rapid hydrolysis of triglycerides from the particles by
lipoprotein lipase and for the delivery of the fatty acids to
the membrane bound fatty acid transporters. Alternatively,
lipid particles are internalized together with HSPGs at
which they have accumulated. In this way, the ECM plays
a crucial role in lipid uptake which is in some way regu-
lated by insulin.
ECM regulation and energy metabolism
Whenpreadipocytesdifferentiateandcellsbegintostorefat,
their ECM adopts a basal laminar structure. Uptake and
storageoffattyacidsdependsongeneregulationthroughthe
activity of the nuclear receptor PPARc in combination with
another nuclear receptor, RXR. The parallel fat-storage and
ECM development suggests that both processes might be
concertedly regulated by PPARc. However, not many genes
forECMcomponentsortheirprocessingenzymeshavebeen
showntobedirecttargetsofPPARc.Suggestiveresultshave
been obtained for COL6A3 and thrombospondin 1 [50]. A
speciﬁc responsive element for binding PPARc exists in the
promoter of the rodent gene for MMP1 [51]. When rosig-
litazone, a strong agonist of PPARc, was added to mature
3T3-L1 adipocytes, the cells lost 10% of their triglycerides.
At the same time, a down-regulation was observed of the
expression of genes for matrix proteins and various pro-
cessing enzymes[52].Thissuggeststhatreductionofthenet
triglyceride content of the cell maybe accompanied by
reduction of the cell volume, while the building-up of the
ECM is slowed down via transcriptional down-regulation.
However, this effect seems not conﬁned to ECM-proteins
but also applies to other secreted proteins.
Table 4 MMPs and their inhibitors
Inhibitor target TIMP1 TIMP2 TIMP3 TIMP4
MMP1 jjjj
MMP2 jjjj
MMP3 jjjj
MMP4 (MMP17)
MMP5 (MMP24)
MMP6 (MMP25)
MMP7 jjjj
MMP8 jj
MMP9 jjjj
MMP10 jj
MMP11 jj
MMP12 jj
MMP13 jjj
MMP14 9 jj
MMP15 jj
MMP16 jj
MMP18
MMP19 j
MMP20
MMP21
MMP22 (MMP23)
j Annotated as substrate, 9 annotated as no interaction
1286 E. C. M. Mariman, P. WangAs mentioned above, an important way to control the
turnover of the ECM in mature adipocytes is by regulating
the processing enzymes for the synthesis and the break-
down of ECM proteins. An interesting protein complex in
this respect is the enzyme prolyl-4-hydroxylase, which is
involved in the modiﬁcation of collagens necessary for
their assembly into collagen monomers and ﬁbrils. It is a
tetramer of two alpha-1 chains (P4HA1) and two beta
subunits, also referred to as protein disulﬁde isomerase
(P4HB, PDI). The location of this complex is most likely
the ER where the alpha-chains of the enzyme complex
convert proline residues in collagens to 4-hydroxyproline.
It requires vitamin C (ascorbic acid) as a cofactor supply-
ing Fe
2? for the reaction. In addition, the reaction requires
O2 and a-ketoglutarate and converts them to CO2 and
succinate, respectively. In principle, this conversion might
be regarded as a shunt in the TCA cycle (Fig. 3) revealing
that one proline hydroxylation costs an energy equivalent
of four ATPs (one GTP and one NADH). Apparently,
collagen synthesis is a considerably energy-costing pro-
cess. In fact, an exchange of metabolites between
mitochondrion and ER as in the presumed shunt is not
unlikely. For rat pancreatic islet mitochondria, it was
shown that a-ketoglutarate is a metabolite of the cataple-
rosis [53]. Moreover, the mitochondria and ER can
establish a direct interaction mediated by speciﬁc contact-
proteins [54]. It was observed that pyruvate enhances the
secretion of a-ketoglutarate from the mitochondria by
fourfold [53]. In this respect, collagen synthesis might be
inﬂuenced by the pyruvate concentration serving as a
substrate for a-ketoglutarate synthesis and promoting its
secretion from the mitochondria. Also, the efﬁcacy of the
reaction, and thereby of ECM and adipocyte development,
seems to depend on the oxygen supply to the tissue. It is
tempting to speculate that this enzyme complex is a site for
oxygen sensing as has been shown for other members of
the gene family, HIF-prolyl hydroxylase [55, 56]. Various
regulatory aspects of the collagen proline hydroxylation are
summarized in Fig. 3.
Protein disulﬁde isomerase (PDI), the molecular partner
of prolyl hydroxylase, functions by creating and rearrang-
ing disulﬁde bonds during protein folding in the ER. In line
with its catalytic properties, the activity of PDI seems to
depend on the redox status in the cell [57, 58]. The folding
of collagens into the proper structure needed for cleavage
of the N-terminal peptide is probably just one of the
numerous sites of action of this enzyme during formation
of ECM components. Not only structural ECM components
but also modifying enzymes like TIMP1 and TIMP2 rely
for their activity on disulﬁde bonds. Through enzymes like
PDI, the redox status of the cell and in particular the
NADH/NAD
? ratio may have a strong inﬂuence on the
turnover of the adipocyte ECM.
ECM regulation and mechanical forces
Although one of the functions of the ECM of adipocytes
is the protection of the cell against disruption by
mechanical forces, this aspect has not been much studied.
When 3T3-L1 pre-adipocytes are subjected to mechanical
stretching, this results in the inhibition of differentiation.
A down-regulation of the expression of the PPARc2 gene
is observed, most likely mediated by the MAPK/ERK
pathway [59]. It suggests that, when external forces are
sensed, cells may spend their energy more on ECM
remodeling, promoting survival than on triglyceride stor-
age. Stretching may also prevent the required change in
morphology during differentiation. A relation between
cell shape and the potential to differentiate was already
demonstrated in 1983 by Spiegelman and Ginty [60].
Allowing 3T3-F442A cells to spread on a ﬁbronectin-
coated surface inhibited differentiation, whereas this
Fig. 3 Summary of the factors
that inﬂuence the activity of the
prolyl hydroxylase/protein
disulﬁde isomerase (PH/PDI)
enzyme complex
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spherical shape.
An interesting observation showing the involvement of
the ECM in cell morphology development was made
in MT1-MMP (MMP14) null mice [38]. Those mice are
lipodystrophic, and their pre-adipocytes in an in vitro
3D-culture system adopt a different cell shape as cells from
wild-type mice. A down-regulation of CREB and phos-
phorylated CREB was noticed. It seems as if the cells have
lost their capacity to interact with surrounding collagen
ﬁbers and thereby lost the traction forces necessary to
change shape. In summary, external mechanical forces on
the cell inﬂuence its power to differentiate and function
properly, whereas traction forces from the cell to the sur-
roundings are necessary for cell morphology development.
The ECM is an intermediate in both processes.
Other regulators of ECM
Besides insulin, other hormones, including leptin [61],
angiotensinII[62],andestrogen[63],havebeenaddressedto
the development of the ECM in other organs but not in adi-
pose tissue. Since adipose tissue expresses these hormones
and also their receptors, it can be expected that the adipose
ECM may also be under the regulation of these hormones,
possiblyviaautocrineandparacrineaction.Whileleptinand
angiotensin II stimulate ECM production via TGF-b, estro-
genprotectsECMbyreducingMMPsandincreasingTIMPs.
The sympathetic nervous system can also be involved in
the regulation of ECM dynamics. The study of vascular
smooth muscle shows that stimulating a1- and b1/b2-
adrenergic receptors induce and inhibit ECM production,
respectively, via TGF-b [64]. Although it has not yet been
addressed directly in adipose tissue, similar mechanisms
may operate through its a2- and b-receptors that play a
major role in the control of lipolysis.
Adipocyte ECM, weight regulation and obesity
One of the main functions of adipose tissue is the tempo-
rary storage of fat as triglycerides. In case of a positive
energy balance, preadipocytes develop into adipocytes,
during which cell shape dramatically alters. This process
depends on changes in the ECM. As outlined in the pre-
vious paragraphs, adipogenesis can be divided in roughly
two phases: a ﬁrst phase in which the cells are committed
to triglyceride storage, and a second phase that relates more
to the vast increase in the amount of triglycerides accom-
panied by rounding and growing of the cells.
If mature adipocytes take up more fat, the cell volume
increases and so should the ECM [65]. In obese subjects,
many of the adipocytes are hypertrophic and the question
arises if and how the ECM can cope with this. It is
tempting to propose that there is a physical limit to adi-
pocyte growth and that this limit is determined by the
ability of the cell to keep the ECM in such a condition that
it can protect the cell against disruption. An emerging view
is that hypertrophy of adipocytes prevents proper oxygen
supply to the cell contents creating a state of hypoxia [66].
Lack of sufﬁcient oxygen will induce apoptosis of some of
the cells, which then attracts macrophages and generates a
state of inﬂammation in the tissue that may be part of the
pathogenesis of obesity-related disorders like type II
diabetes. Not much is known about the mechanistic con-
sequences of hypoxia, but the ECM may be involved.
Hypoxia will undoubtedly induce a change in cellular
redox status and, as mentioned above, this will lead to
malfunctioning of ECM-protein processing enzymes like
lysyl oxidase and prolyl-4-hydroxylase, the crucial enzyme
for collagen synthesis. In obese insulin-resistant persons,
proline hydroxylation may be inhibited even more because
of a decreased supply of pyruvate as input for the TCA
cycle. Under those conditions, one might expect a desta-
bilization of the ECM with dramatic consequences for the
ever-growing adipocytes. As such, the ECM may be an
important player in the etiology of type II diabetes. Cul-
turing immortalized or primary rodent adipocytes under
high glucose/high insulin concentration or inducing insulin
resistance in those cells by the addition of PUGNAc [67]
leads to altered composition of the ECM with changes in
the relative abundance of several ECM proteins (laminin
b-1 chain, spondin 1, ﬁbulin 2) and matrix processing
enzymes (peptidyl–prolyl cis–trans isomerase B, MMP2,
TIMP2) [11]. Khan et al. [16] also reported that the met-
abolic dysregulation of the body in the diabetic state is
linked to changes of the adipocyte ECM. Allowing
their stress-free expansion by knocking-out collagen VI
improved whole body energy homeostasis.
Not much is known about the dynamics of the ECM
during a negative energy balance. Yet this is important
since, for the obese, the loss of fat mass is a preferred way
to lower the risk for complications. When 3T3-L1 adipo-
cytes are starved, they readily lose about 46% of their fat,
but then this process comes to a stop, which can only be
overcome by additional measures. Supplementation of the
culture medium with TNFa leads to a further reduction of
the fat content to 77% [68]. One could speculate that the
loss of triglycerides decreases the volume of the cell cre-
ating stress between the cell contents and the surrounding
ECM. This would require the ECM to remodel. However,
shrinkage of the ECM may be hard or even impossible. In
either case, stress will build up between cell and ECM, and
this may inhibit lipolysis explaining why fat loss from
adipocytes cannot reach completion. Indeed, 10% fat loss
by rosiglitazone treatment was paralleled by transcriptional
1288 E. C. M. Mariman, P. Wangdown-regulation of synthesis and processing of ECM pro-
teins [52].
Inﬂammation is linked to obesity. Adipocytes in the
obese increase their cytokine production and attract mac-
rophages, which contribute to an enhanced systemic
inﬂammation status. On the other hand, macrophages
stimulate adipose tissue remodeling by macrophage-
released MMP [69] and/or induced adipocytes-expressed
MMPs [70], and may as such change adipocyte functioning.
Several other studies indicate a link between the ECM
and weight regulation. Knocking-out collagen VI in the
ob/ob mouse decreased body weight due to reduced fat mass
at young age [16]. SPARC-null mice that exhibit increased
adiposity [71] display a strong inﬂuence on the ECM con-
version from a ﬁbronectin-rich stroma to a laminin-rich
basal lamina [72]. Human proof comes from drug treatment.
HIV 1-infected patients receiving protease inhibitors as
anti-viral therapy often develop peripheral fat wasting with
difﬁculties in adipogenesis and fat accumulation [73]. This
treatment was shown to change the activity of the endoge-
nous proteases MMP2 and MMP9 as well as of other
processing enzymes [74]. It suggests that adipogenesis and
adipocyte stability may be affected by interfering with ECM
dynamics. At the epidemiological level, increased plasma
concentrations of MMP2 and MMP9 have been reported in
obese adults [75], and increased levels of MMP9 and
TIMP1 in obese children [76]. Plasma levels of TIMP1 have
been found to be associated with adiposity in humans [42].
A genetic study with polymorphisms in the promoter region
of the MMP1 gene among Korean subjects resulted in a
signiﬁcant association with BMI [77].
Summary
Although many observations are from in vitro experiments,
it seems reasonable to state that two phases can be distin-
guished during adipogenesis. In the ﬁrst phase,
preadipocytes become committed to the storage of triglyc-
erides. Synthesis of laminar collagens and of other
components of the basal lamina is increased while the
network of ﬁbrillar collagens around the cell is maintained.
In this phase, blocking prolyl-4-hydroxylase prevents dif-
ferentiation and triglyceride storage. Mediated by a
complex set of processing enzymes of which the activity is
neatly regulated, the developing cell becomes embedded in
the basal lamina. During the second phase, the adipocyte
accumulates vast amounts of triglycerides accompanied by
a change in cell shape and cell growth. Traction forces
between cell and the surrounding meshwork mediated by
the ECM are necessary for this process to occur. A situation
is reached in which the ﬁbrillar network functions as an
outer skeleton protecting the adipocyte from mechanical
disruption, and in which the laminar scaffold reduces
external forces by spreading them over the tissue. Conse-
quently, mature adipocytes spend considerable energy in
maintaining and renewing their ﬁbrillar network. ECM
formation is stimulated by insulin through the transcrip-
tional up-regulation of genes for processing enzymes.
Further, being the source of pyruvate, glucose supports
collagen synthesis via stimulation of the prolyl-hydroxy-
lase/PDI complex. Other control conditions are the redox
status and the supply of oxygen. In obesity, hypoxia may
negatively inﬂuence ECM maintenance leading to ECM
instability, cell death, and the attraction of macrophages.
Alternatively, hypertrophy of adipocytes may be directly
linked to ECM instability. Loss of fat mass from adipocytes
during calorie restriction seems limited. This may be the
consequence of the stress build-up between the shrinking
cell volume and the rigid ECM, but this hypothesis still
needs experimental proof. It isclear, however,that the ECM
plays an important and often ignored role in adipocyte
development and function and as such in lipid metabolism,
weight regulation, and obesity.
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